Shanqing Li

2.2k total citations
115 papers, 1.3k citations indexed

About

Shanqing Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shanqing Li has authored 115 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 39 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Shanqing Li's work include Lung Cancer Diagnosis and Treatment (38 papers), Lung Cancer Treatments and Mutations (34 papers) and Cancer-related molecular mechanisms research (13 papers). Shanqing Li is often cited by papers focused on Lung Cancer Diagnosis and Treatment (38 papers), Lung Cancer Treatments and Mutations (34 papers) and Cancer-related molecular mechanisms research (13 papers). Shanqing Li collaborates with scholars based in China, United States and Italy. Shanqing Li's co-authors include Naixin Liang, Chao Guo, Zhili Cao, Dongjie Ma, Zhijun Han, Yeye Chen, Kaidi Li, Xiaoyun Zhou, Yingzhi Qin and Hongsheng Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Radiology.

In The Last Decade

Shanqing Li

100 papers receiving 1.3k citations

Peers

Shanqing Li
Jian Feng China
Ho Jung An South Korea
Ling Guo China
Shanqing Li
Citations per year, relative to Shanqing Li Shanqing Li (= 1×) peers Nerina Denaro

Countries citing papers authored by Shanqing Li

Since Specialization
Citations

This map shows the geographic impact of Shanqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanqing Li more than expected).

Fields of papers citing papers by Shanqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanqing Li. The network helps show where Shanqing Li may publish in the future.

Co-authorship network of co-authors of Shanqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shanqing Li. A scholar is included among the top collaborators of Shanqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanqing Li. Shanqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linlin, Chao Guo, Xiaoyun Zhou, et al.. (2025). Clinical Application of 68Ga-Pentixafor PET/CT for the Detection of Thymoma: A Pilot Study. Clinical Nuclear Medicine. 50(5). 388–393. 1 indexed citations
2.
Gao, Chao, Jiaqi Zhang, Xin Du, et al.. (2025). Prognostic determinants and functional role of PIK3C2G in stage IIb-IIIa lung adenocarcinoma: insights from clinical and molecular analyses. Frontiers in Oncology. 14. 1473437–1473437.
3.
Yang, Libing, Chao Guo, Zhang Ye, et al.. (2024). Simultaneous bilateral video-assisted thoracic surgery is safe and feasible for multiple primary lung cancers. Journal of Cardiothoracic Surgery. 19(1). 436–436.
4.
Huang, Zhicheng, Yadong Wang, Chao Guo, et al.. (2024). Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two‐sample Mendelian randomization study. Thoracic Cancer. 15(21). 1673–1680. 3 indexed citations
5.
Huang, Zhicheng, Yadong Wang, Yuan Xu, et al.. (2024). Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic Cancer. 15(24). 1825–1828. 1 indexed citations
6.
Cao, Zhen, Xiayao Diao, Jiaqi Zhang, et al.. (2024). Clinicopathological features and outcomes of rare lung adenocarcinoma metastasis to the thyroid gland: A single‐center, 11‐year experience. Thoracic Cancer. 16(1). e15486–e15486.
7.
Diao, Xiayao, Yi Zeng, Xiao‐Jiang Chen, et al.. (2023). Physical activity and cancer risk: a dose‐response analysis for the Global Burden of Disease Study 2019. Cancer Communications. 43(11). 1229–1243. 31 indexed citations
8.
Li, Bowen, Ziqi Jia, Zhicheng Huang, et al.. (2023). Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report. Translational Lung Cancer Research. 12(11). 2322–2329. 2 indexed citations
9.
Zhao, Ke, Yeye Chen, Lei Liu, et al.. (2023). Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma. Thoracic Cancer. 14(15). 1339–1347. 2 indexed citations
10.
Cao, Lei, Chao Guo, Luo Zhao, et al.. (2023). USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway. Biology Direct. 18(1). 16–16. 9 indexed citations
11.
Xu, Yuan, Dongjie Ma, Yingzhi Qin, et al.. (2023). Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?. Thoracic Cancer. 14(17). 1635–1639. 5 indexed citations
12.
Li, Haochen, et al.. (2023). [Recent Advances and Controversies in Minute Pulmonary Meningothelial-like Nodules].. SHILAP Revista de lepidopterología. 26(8). 621–629.
13.
Liu, Lei, Jiaqi Zhang, Ke Zhao, et al.. (2023). The 100 most cited papers on thymoma: a bibliometric analysis. Journal of Cardiothoracic Surgery. 18(1). 107–107. 2 indexed citations
14.
Diao, Xiayao, Chao Guo, & Shanqing Li. (2022). Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets. Cancer Communications. 42(12). 1403–1406. 5 indexed citations
15.
Zhang, Jiaqi, et al.. (2022). Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options. Respiratory Medicine and Research. 86. 100961–100961. 1 indexed citations
17.
Yang, Huaxia, Yadong Wang, Ziqi Jia, et al.. (2021). Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer. Frontiers in Oncology. 11. 537735–537735. 9 indexed citations
18.
Song, Yang, Ziqi Jia, Yadong Wang, et al.. (2020). Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. Journal of Thoracic Disease. 12(5). 2771–2780. 5 indexed citations
19.
Zhang, Jing, et al.. (2018). Estrogen‐related receptor alpha triggers the proliferation and migration of human non‐small cell lung cancer via interleukin‐6. Cell Biochemistry and Function. 36(5). 255–262. 19 indexed citations
20.
He, Jia, Dongjie Ma, & Shanqing Li. (2017). Uniportal video-assisted thoracoscopic right upper lobectomy and systemic mediastinal lymph nodes dissection. Journal of Thoracic Disease. 9(6). 1644–1647. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026